We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
-4%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.26B
AUM Growth
-$362M
Cap. Flow
-$5M
Cap. Flow %
-0.12%
Top 10 Hldgs %
43.71%
Holding
683
New
46
Increased
475
Reduced
93
Closed
17

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$38.3M
2
AMZN icon
Amazon
AMZN
+$27.7M
3
PLTR icon
Palantir
PLTR
+$17.5M
4
HIMS icon
Hims & Hers Health
HIMS
+$13.7M
5
YUMC icon
Yum China
YUMC
+$13.2M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$39.4M
2
NVDA icon
NVIDIA
NVDA
+$30.1M
3
META icon
Meta Platforms (Facebook)
META
+$14.9M
4
BEKE icon
KE Holdings
BEKE
+$14.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 42.45%
2 Consumer Discretionary 16.26%
3 Communication Services 14.17%
4 Healthcare 8.06%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MPT
401
Medical Properties Trust
MPT
$2.77B
$61.7K ﹤0.01%
10,235
-126
-1% -$637
BNL icon
402
Broadstone Net Lease
BNL
$4.11B
$60.9K ﹤0.01%
3,571
+145
+4% +$2.35K
TWST icon
403
Twist Bioscience
TWST
$5.7B
$59.7K ﹤0.01%
1,520
+274
+22% +$12.3K
HIW icon
404
Highwoods Properties
HIW
$3.65B
$59.5K ﹤0.01%
2,008
+82
+4% +$2.39K
VCYT icon
405
Veracyte
VCYT
$3.7B
$58.8K ﹤0.01%
1,984
+357
+22% +$13.6K
CDP icon
406
COPT Defense Properties
CDP
$4.3B
$58.2K ﹤0.01%
2,134
+87
+4% +$2.45K
VCEL icon
407
Vericel Corp
VCEL
$2.35B
$56.4K ﹤0.01%
1,264
+228
+22% +$12.3K
APLE icon
408
Apple Hospitality REIT
APLE
$3.9B
$55.7K ﹤0.01%
4,317
+161
+4% +$2.35K
MIRM icon
409
Mirum Pharmaceuticals
MIRM
$6.46B
$55.3K ﹤0.01%
1,228
+220
+22% +$10.4K
CB icon
410
Chubb
CB
$135B
$54.7K ﹤0.01%
+181
New +$50.3K
WM icon
411
Waste Management
WM
$90.6B
$54.6K ﹤0.01%
+236
New +$52.3K
PGR icon
412
Progressive
PGR
$123B
$54.6K ﹤0.01%
+193
New +$50.5K
NSA
413
DELISTED
National Storage Affiliates Trust
NSA
$54.1K ﹤0.01%
1,372
+61
+5% +$2.3K
IBRX icon
414
ImmunityBio
IBRX
$7.51B
$53.7K ﹤0.01%
17,843
+3,211
+22% +$9.73K
EWTX icon
415
Edgewise Therapeutics
EWTX
$4.13B
$53.3K ﹤0.01%
2,424
+436
+22% +$11.4K
FCPT icon
416
Four Corners Property Trust
FCPT
$2.81B
$52.6K ﹤0.01%
1,832
+148
+9% +$4.13K
RXRX icon
417
Recursion Pharmaceuticals
RXRX
$1.59B
$51.7K ﹤0.01%
9,775
+1,759
+22% +$12.8K
LGND icon
418
Ligand Pharmaceuticals
LGND
$5.76B
$50.9K ﹤0.01%
484
+87
+22% +$9.84K
DEI icon
419
Douglas Emmett
DEI
$1.98B
$50.7K ﹤0.01%
3,171
+129
+4% +$2.19K
TARS icon
420
Tarsus Pharmaceuticals
TARS
$2.58B
$50.2K ﹤0.01%
978
+175
+22% +$8.65K
DNLI icon
421
Denali Therapeutics
DNLI
$3.65B
$50.1K ﹤0.01%
3,685
+663
+22% +$12.7K
NVCR icon
422
NovoCure
NVCR
$1.73B
$49.4K ﹤0.01%
2,770
+498
+22% +$11.3K
HRMY icon
423
Harmony Biosciences
HRMY
$2.04B
$48.5K ﹤0.01%
1,460
+262
+22% +$9.39K
NAMS icon
424
NewAmsterdam Pharma
NAMS
$3.25B
$48.4K ﹤0.01%
2,365
+425
+22% +$9.45K
ZLAB icon
425
Zai Lab
ZLAB
$2.06B
$48.3K ﹤0.01%
1,336
+241
+22% +$7.41K
15 16
17
18 19

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q1 2025 Portfolio in Review

As of Q1 2025, GF Fund Management held 683 positions worth $4.26B, down 7.8% from $4.62B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q1 2025 filing shows 46 new, 475 increased, 93 reduced and 17 closed positions. Its largest new stake was Hims & Hers Health: 368,661 shares worth $10.9M. The largest sale was Pinduoduo, an estimated $39.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q1 2025 buy was Hims & Hers Health: 368,661 shares worth $10.9M.
  • GF Fund Management added most to Philip Morris in Q1 2025, an estimated $38.3M increase.
  • GF Fund Management's biggest Q1 2025 reduction was Pinduoduo, cutting an estimated $39.4M.
  • GF Fund Management fully exited Applied Optoelectronics in Q1 2025, selling an estimated $5.07M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.26B portfolio in Q1 2025.
  • GF Fund Management opened 46 new positions and closed 17 in Q1 2025.
  • GF Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.26B.

Based on GF Fund Management's 13F filing for Q1 2025, filed 29 Apr 2025.